ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

407
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Refresh
bullishCelltrion Inc
04 Dec 2023 17:56

Alpha Generation Through Share Buybacks in Korea: October & November 2023

In this insight, we discuss the alpha generation through companies that announced share buybacks in Korea in October and November 2023.

Logo
Douglas Kim
78 Views
Share
bullishCelltrion Inc
15 Nov 2023 01:12

Progress of Merger Between Celltrion Inc and Celltrion Healthcare & Appraisal Rights Issue

On 14 November, Celltrion Inc announced the total amount of stock purchase rights exercised in the merger of Celltrion Inc and Celltrion Healthcare...

Logo
Douglas Kim
808 Views
Share
bullishCelltrion Inc
11 Nov 2023 15:07

Celltrion (068270 KS): Record High Revenue and Operating Profit in 3Q23 Solidify Merger Stance

in 3Q23, ​Celltrion reported sales and op. profit of KRW672B (+4% YoY) and KRW268B (+25% YoY), respectively. Op. profit margin is at 2 year high....

Logo
Tina Banerjee
429 Views
Share
bullishCelltrion Inc
02 Nov 2023 05:40

Celltrion Merger: Appraisal Rights & Passive Flows

The appraisal rights exercise period ends 13 Nov. Both companies are buying back shares. The last traded price is close to the appraisal price....

Logo
Brian Freitas
403 Views
Share
bullishCelltrion Inc
24 Oct 2023 10:13

Celltrion Merger: Index Implications

Celltrion Inc (068270 KS) and Celltrion Healthcare (091990 KS) shareholders have approved the merger. The last trading day is expected to be 28...

Share
x